<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/94C0A5AB-B9B8-4BC9-8F73-5D0B17CB855B"><gtr:id>94C0A5AB-B9B8-4BC9-8F73-5D0B17CB855B</gtr:id><gtr:firstName>Bettina</gtr:firstName><gtr:surname>Wilm</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B73AA20-F6F4-447A-8869-903BBDD645A3"><gtr:id>9B73AA20-F6F4-447A-8869-903BBDD645A3</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Harold</gtr:otherNames><gtr:surname>Edgar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C5B3C014-7214-4520-A2DF-C24DA1134F0F"><gtr:id>C5B3C014-7214-4520-A2DF-C24DA1134F0F</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Kenny</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/55BBBE52-3198-4B5A-ADE7-6F7EE6BF38A3"><gtr:id>55BBBE52-3198-4B5A-ADE7-6F7EE6BF38A3</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Fernig</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802548"><gtr:id>5C2C3152-1AC0-4D7C-B41E-BBB648F288C7</gtr:id><gtr:title>Development nanoparticle-based techniques to monitor differentiating neural stem cells after transplantation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802548</gtr:grantReference><gtr:abstractText>There is much excitement about the possibility of using stem cells to replace diseased, damaged or even underdeveloped tissues. However, before such therapies can be devised, we need to be able to follow what happens when stem cells (or the cells they develop into) are transplanted into the body. Our project intends to make use of another recent scientific development, using nanotechnology to be able to follow the development of stem cells. To do this, we will modify the chemistry of metallic nanoparticles (which have diameters of less than ten thousandth of a millimeter) so that they are taken up by stem cells. By observing the localisation of these particles we can in turn locate the stem cells which took them up, even though those stem cells may have already developed into different types of cell.</gtr:abstractText><gtr:technicalSummary>Although there is currently increasing research using nanoparticle-based imaging to track stem cells and their derivatives, little work has been done to develop these techniques so that the nanoparticles are directed to specific sub-cellular locations. Such specificity is necessary for example, if developing axons are to be followed after transplantation of neural stem cells or their derivatives. This proposal therefore seeks to optimize nanoparticle-based cell tracking techniques to achieve subcellular localisation, demonstrated by comparison with existing lentiviral-based fluorescent protein reporter assays. To do this, we will build on two previously unconnected fields of research in Liverpool (a) the development of physico-chemical methods for the construction and modification of a variety of nanoparticles (including Quantum-dots and gold nanoparticles), which will be used to produce nanoparticles modified with a variety of cell specific targeting ligands and (b) the development of an in vitro assay system that faithfully reproduces the migration and differentiation of enteric nervous system stem cells to innervate the gut, which can be used to assess the ability of the nanoparticles to follow cell development of developing neurones and their axons after transplantation. Production of such nanoparticle reagents will aid to future clinical development and is also likely to be of relevance to a variety of next-generation nano medical applications.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>252708</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>56593</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Royal College of Surgeons of England</gtr:fundingOrg><gtr:id>D6C1BF51-D421-456D-981D-5AD3EAFFFBC8</gtr:id><gtr:outcomeId>oBiS6qJDASg0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>139980</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Training Fellowship</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>DD3CB94D-9972-4B3A-8F92-AA92F205F7B1</gtr:id><gtr:outcomeId>PUiv3Yjcczt0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>68F50C05-A7E5-4E7B-A334-06A1C322169B</gtr:id><gtr:title>The influence of high intensity terahertz radiation on mammalian cell adhesion, proliferation and differentiation.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6682b85c220c8c8bd534e7066c4856a9"><gtr:id>6682b85c220c8c8bd534e7066c4856a9</gtr:id><gtr:otherNames>Williams R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>pm_14877_27_23257566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78412DFB-831B-4A9B-BE11-330D35F354F2</gtr:id><gtr:title>Quantum dots do not affect the behaviour of mouse embryonic stem cells and kidney stem cells and are suitable for short-term tracking.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75032eeb417ea0c37218bbf02230e108"><gtr:id>75032eeb417ea0c37218bbf02230e108</gtr:id><gtr:otherNames>Rak-Raszewska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14877_27_22403689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC28499-4106-4BE8-9D92-8DD676F08695</gtr:id><gtr:title>Properties of secondary and tertiary human enteric nervous system neurospheres.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d46a1a3ac020d2266fc98827c705ab3e"><gtr:id>d46a1a3ac020d2266fc98827c705ab3e</gtr:id><gtr:otherNames>Lindley RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3468</gtr:issn><gtr:outcomeId>fqupCLyVbwe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5758CA02-7768-404F-A9CA-1FDE2056634B</gtr:id><gtr:title>Regulation of progenitor cell proliferation and neuronal differentiation in enteric nervous system neurospheres.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35afc9471482739986ec5de4c07d5a69"><gtr:id>35afc9471482739986ec5de4c07d5a69</gtr:id><gtr:otherNames>Theocharatos S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14877_27_23372773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B142448D-89AD-4C63-AEDF-EA9189B1ADA7</gtr:id><gtr:title>Stem cells derived from neonatal mouse kidney generate functional proximal tubule-like cells and integrate into developing nephrons in vitro.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e4f5db4c1c7e1594ce6bc06f4ae8bd4"><gtr:id>8e4f5db4c1c7e1594ce6bc06f4ae8bd4</gtr:id><gtr:otherNames>Ranghini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14877_27_23667549</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802548</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>0CDFB83C-594C-4860-B0BE-C82CA4D45B6B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>